NCT05801835 2023-09-21
A Bioequivalence Study of (Cytarabine: Daunorubicin) Liposome for Injection
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Phase NA Unknown
Clinical Trials
5 trialsNCT03709914 2023-09-15
Pediatric_PK
Nabriva Therapeutics AG
Phase 1 Unknown
NCT06008405 2023-09-06
Clinical Trial Evaluating the Safety of the TQB2928 Injection Combination Therapy
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT04604691 2022-03-08
Blinatumomab in Pediatric B-cell Acute Lymphoblastic Leukemia (ALL) With Minimal Residual Disease (MRD)
Seoul National University Hospital
Phase 1 Unknown
NCT04920500 2021-06-09
Bioequivalence of Daunorubicin Cytarabine Liposomes in Naive AML Patients
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Phase NA Unknown